The University of Chicago Header Logo

Connection

Richard Koya to Programmed Cell Death 1 Receptor

This is a "connection" page, showing publications Richard Koya has written about Programmed Cell Death 1 Receptor.
  1. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med. 2015 Mar 18; 7(279):279ra41.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.